ADENOSINE A3 RECEPTORS: A NEW THERAPEUTIC APPROACH IN CANCER.

被引:2
|
作者
Gaspar, Alexandra [1 ]
Silva, Tiago [1 ]
Borges, Fernanda [1 ]
机构
[1] Univ Porto, Fac Ciencias, Dept Quim & Bioquim, P-4000 Oporto, Portugal
来源
QUIMICA NOVA | 2011年 / 34卷 / 08期
关键词
cancer; AR A(3); ligands; HIGHLY POTENT; SPECIES-DIFFERENCES; PHARMACOLOGICAL EVALUATION; SELECTIVE ANTAGONISTS; PURINE DERIVATIVES; MELANOMA-CELLS; LIGANDS; AGONISTS; SERIES; AFFINITY;
D O I
10.1590/S0100-40422011000800022
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
ADENOSINE A(3) RECEPTORS: A NEW THERAPEUTIC APPROACH IN CANCER. Cancer is a multi-factorial disease linked with different initiating causes, cofactors and promoters, and several types of cellular damage. Advancing knowledge on the cellular and molecular biology of the processes that regulate cell proliferation, cell differentiation and cellular responses to external signals, has provided a wealth of information about the cancer cell and how it differs from a normal one. These findings make available a number of potential targets for new therapeutic approaches. The Medicinal Chemistry artwork performed so far in the development of selective and potent adenosine receptor A(3) ligands, a current cancer target, will be highlighted in this work.
引用
收藏
页码:1417 / 1424
页数:8
相关论文
共 50 条
  • [31] Renal adenosine A3 receptors in the rat:: assessment of functional role
    Mozaffari, MS
    Abebe, W
    Warren, BK
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (05) : 428 - 432
  • [32] Knockout of A3 adenosine receptors reduces mouse intraocular pressure
    Avila, MY
    Stone, RA
    Civan, MM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (09) : 3021 - 3026
  • [33] Rapid stimulation of presynaptic serotonin transport by A3 adenosine receptors
    Zhu, Chong-Bin
    Steiner, Jennifer A.
    Munn, Jaclyn L.
    Daws, Lynette C.
    Hewlett, William A.
    Blakely, Randy D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (01): : 332 - 340
  • [34] A3 adenosine receptor as a target for cancer therapy
    Fishman, P
    Bar-Yehuda, S
    Madi, L
    Cohn, I
    ANTI-CANCER DRUGS, 2002, 13 (05) : 437 - 443
  • [35] BCUT descriptors for predicting affinity toward A3 adenosine receptors
    González, MP
    Terán, C
    Teijeira, M
    Besada, P
    González-Moa, MJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (15) : 3491 - 3495
  • [36] A pore for adenosine A3 receptors in ischemic preconditioning in the human atrium
    Carr, CS
    Hill, RJ
    Masamune, H
    Kennedy, SP
    Knight, DR
    Tracey, WR
    Yellon, DM
    CIRCULATION, 1996, 94 (08) : 3220 - 3220
  • [37] A novel skeletal muscle cytoprotective action of adenosine A3 receptors
    Zheng, Jingang
    Wang, Rubio
    Zambraski, Edward
    Wu, Dan
    Jacobson, Kenneth
    Liang, Bruce
    FASEB JOURNAL, 2007, 21 (06): : A800 - A800
  • [38] Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors
    Cao, Hong-Li
    Liu, Zi-Jin
    Chang, Zheng
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 6
  • [39] Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells
    Gessi, S
    Cattabriga, E
    Avitabile, A
    Gafa, R
    Lanza, G
    Cavazzini, L
    Bianchi, N
    Gambari, R
    Feo, C
    Liboni, A
    Gullini, S
    Leung, E
    Mac-Lennan, S
    Borea, PA
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5895 - 5901
  • [40] Caspase Inhibition Via A3 Adenosine Receptors: A New Cardioprotective Mechanism Against Myocardial Infarction
    Afthab Hussain
    Ahmed Mayel Gharanei
    Aarondeep Singh Nagra
    Helen L. Maddock
    Cardiovascular Drugs and Therapy, 2014, 28 : 19 - 32